Graphical Abstract Highlights d SMAC mimetics selectively induce apoptosis in HIV-infected resting memory CD4+ T cells d SMAC mimetic-mediated apoptosis is dependent upon autophagy induction and factors d SMAC mimetics exploit autophagy proteins to assemble a death-inducing signaling complex d Inhibition of autophagy induction, but not degradation, abrogates SMAC mimetic efficacy SUMMARY Long-lived resting memory CD4+ T cells (T CM ) are a major reservoir of latent HIV infection. We hypothesized that latent HIV-T CM cells are maintained by aberrant expression of cell survival factors, including XIAP, BIRC2/cIAP1, and beclin-1. DIABLO/SMAC mimetics are therapeutic agents that compromise cell survival by hijacking host apoptotic machinery.
In Brief
Ineffective eradication of HIV reservoirs impedes cure. Campbell et al. reveal that DIABLO/SMAC mimetics trigger apoptosis in HIV-infected resting memory CD4+ T cells, while having minimal effect on uninfected cells. This selective killing requires the induction of autophagy and formation of a ripoptosome-like cytosolic death-inducing signaling complex.
INTRODUCTION
The major obstacle to eradicating human immunodeficiency type-1 (HIV) is the establishment of long-lived reservoirs of virus. Latently infected cells containing replication-competent proviral DNA may survive for months to years and undergo proliferative renewal. Although antiretroviral therapy (ART) effectively suppresses HIV replication, persistent residual low-level viremia maintains the latent pool (Hermankova et al., 2001; Ramratnam et al., 2000) . The very low expression of viral proteins enables latently infected cells to evade detection and clearance by the immune system. Thus, lifelong ART is required for continued viral suppression.
Autophagy is a degradation pathway that occurs at basal levels in all cells whereby cytosolic double membrane-bound compartments termed autophagosomes engulf and sequester cytoplasmic constituents such as sub-cellular organelles and microbial pathogens. Fusion with a lysosome generates an autolysosome, which enzymatically degrades the engulfed components. Autophagy is upregulated in response to stress such as starvation, drug treatment, and infection, and although predominantly a cell survival mechanism, under certain cellular conditions it can promote cell death (Fitzwalter and Thorburn, 2015) . For example, autophagy promotes Fas cell surface death receptor (FAS)-mediated apoptosis by selectively degrading protein tyrosine phosphatase non-receptor type 13 (PTPN13), a negative regulator of FAS signaling in type I cells (Gump et al., 2014) . In contrast, autophagy can also protect against tumor necrosis factor (TNF) superfamily member 10-induced apoptosis by controlling the levels of the pro-apoptotic BCL2-binding component 3 (BBC3) (Thorburn et al., 2014) .
During HIV infection, CD4+ T cells produce interleukin (IL) 2, upregulate FAS and other pro-apoptotic molecules, and change from an apoptosis-resistant state to a post-activation and apoptosis-prone state. However, the expression of apoptosis regulatory proteins such as BCL2 family members and the inhibitor of apoptosis proteins (IAP) govern the susceptibility of the cell to undergo FAS-mediated death. HIV alters the transcriptional profile of some cell types to produce more endogenous apoptosis regulatory proteins. For example, HIV Tat upregulates anti-apoptotic proteins including BCL2, CFLAR (caspase [CASP] 8 and Fas-associated via death domain [FADD]-like apoptosis regulator), X-linked inhibitor of apoptosis (XIAP), and baculoviral IAP repeat containing 2 (BIRC2, formerly known as cIAP1) (Ló pez-Huertas et al., 2013) . Similarly, HIV Nef induces the phosphorylation and inactivation of pro-apoptotic BCL2associated agonist of cell death (BAD) (Wolf et al., 2001) .
Overexpression of IAPs can inhibit cell death through a number of mechanisms, including direct inhibition of caspases and ubiquitination of receptor-interacting protein kinase (RIPK) 1, a potent activator of multiple forms of programmed cell death. Ubiquitinated RIPK1 can downregulate FAS signaling through NFKB-dependent proinflammatory signaling. Therefore, RIPK1 is a key convergence point between pro-death, pro-survival, and proinflammatory signals. Upon activation of the intrinsic apoptosis pathway, mitochondria release both cytochrome c (legend continued on next page) and diablo IAP-binding mitochondrial protein (DIABLO, formerly known as second mitochondria-derived activator of caspase [SMAC] ). DIABLO is a pro-apoptotic protein that binds to and antagonizes IAP proteins. DIABLO directly competes with caspases for XIAP binding, liberating caspases for apoptosis. It can also stimulate the E3 ubiquitin ligase activity of BIRC2 and BIRC3 (formerly known as cIAP2), triggering their degradation via the proteasome. To circumvent the ability of IAP to turn pro-death into pro-survival signals, small-molecule DIABLO/ SMAC peptidomimetics (SM) were developed that mimic the N-terminal four amino acid sequence of DIABLO required for IAP binding. The interaction of SM with XIAP leads to caspase activation (Gao et al., 2007) , while the binding of SM to BIRC2 and BIRC3 enhances their E3 ligase activity, promoting their autoubiquitination and proteasomal degradation with subsequent cell death (Bertrand et al., 2008; Varfolomeev et al., 2007) . A number of SM are in clinical trials as cancer therapeutics. IAP are relevant targets for therapeutic exploitation in HIV since they block programmed cell death, and both primary cells and cell lines latently infected with HIV display enhanced XIAP and BIRC2 expression (Berro et al., 2007; Ló pez-Huertas et al., 2013) , which may play a role in the establishment of latency and cytopathogenesis (Wang et al., 2011) . Moreover, BIRC2 and BIRC3 specifically mediate macrophage resistance to HIV Vpr-induced apoptosis (Busca et al., 2012) , and alvocidib, a flavonoid alkaloid cyclin-dependent kinase 9 (CDK9) inhibitor, downregulates XIAP and significantly induces the latently infected ACH-2 cell line, but not the uninfected parental cell line, to undergo apoptosis (Berro et al., 2007) . In this study, we examined the potential application of the SM embelin, GDC-0152, and birinapant to induce selective cell death in CD4+ T cells infected with HIV in vitro and ex vivo.
RESULTS

FAS, FASLG, XIAP, and BIRC2 Are Upregulated in HIV-Infected CD4+ T Cells
In HIV-infected individuals, CD4+ T cells overexpress Fas ligand (FasL or FASLG), are more susceptible to FASLG-induced apoptosis (Silvestris et al., 1996) , and the rate of apoptosis correlates with surface levels of both FAS and FASLG (Silvestris et al., 1996) . Therefore, we assessed the expression of FASLG and FAS in HIV-infected, resting central memory CD4+ T cells (HIV-T CM ) compared with resting, mock-infected central memory CD4+ T cells (T CM ). We observed enhanced expression of FAS as well as both membrane-bound and soluble FASLG in HIV-T CM compared with T CM (Figure 1A ). Contrary to this, ACH-2 express similar levels of FAS as A3.01 while FASLG expression is downregulated ( Figure 1B ) (Pinti et al., 1999) . FAS activation of apoptotic pathways in different cell types may be associated with differences in the extent of FAS aggregation or internalization, caspase cascade activation, and/or the levels of caspase inhibitors such as BIRC2 and XIAP. There-fore, we examined the expression of BIRC2 and XIAP as ACH-2 cells have increased expression of XIAP and BIRC2 ( Figure 1C ) (Berro et al., 2007) ; XIAP and BIRC2 ( Figure 1D ) were significantly upregulated in HIV-T CM from all donors. Upregulation of XIAP and BIRC2 leads to increased expression of beclin 1 (BECN1) through the activation of NFKB. Consistent with this, BECN1 expression was increased in HIV-T CM (Figure 1E) . Unlike other BH3-only proteins, the overexpression of BECN1 does not function as a pro-apoptotic signal but instead leads to increased autophagy (Lin et al., 2015) . As HIV requires autophagy for replication (Campbell and Spector, 2013) , we assessed the autophagic status of HIV-T CM . During autophagy, an ubiquitin-like system that involves autophagy related (ATG) 7, ATG3, and the ATG12-ATG5 complex converts cytosolic microtubule-associated protein 1 light chain 3 beta (MAP1LC3B or LC3B)-I to LC3B-II. The ATG12-ATG5 complex then ligates LC3B-II to the nascent autophagosome membrane. The polyubiquitin-binding protein sequestosome 1 (SQSTM1, p62) and SQSTM1-bound polyubiquitinated proteins are also incorporated into completed autophagosomes. These autophagosomes then fuse with lysosomes, resulting in the degradation of the engulfed components as well as the LC3B-II and SQSTM1 associated with the inner membrane. Thus, the quantification of SQSTM1 and the conversion of LC3B-I to LC3B-II and its turnover are indicators of autophagy induction and flux (Klionsky et al., 2016) . Compared with T CM we observed a significant increase in LC3B-II and no change in SQSTM1 expression in HIV-T CM . The latter resulted in a decrease in the SQSTM1:BECN1 protein ratio (Kara et al., 2013) and suggested augmented autophagy induction but an arrest in autophagic degradation. To confirm this, we used bafilomycin A 1 , an inhibitor of V-ATPase and thus autophago-lysosome fusion and lysosomal degradation (Klionsky et al., 2016) . LC3B-II and SQSTM1 were both increased, suggesting increased autophagy induction ( Figure 1F ).
SMAC Mimetics Trigger Rapid Degradation of BIRC2 and XIAP
As both BIRC2 and XIAP are upregulated in HIV-T CM , we examined the effect of the SM GDC-0152, embelin, and birinapant on BIRC2 and XIAP content in HIV-T CM and T CM . All three SM induced a dose-dependent rapid degradation of both XIAP and BIRC2 that became significant at one-tenth the concentration in HIV-T CM compared with T CM (Figure 1G ). Although SM induce the proteasomal degradation of IAP, we examined whether they also stimulate autophagy in HIV-T CM . In T CM , SM induced an increase in BECN1 expression and LC3B conversion but no significant SQSTM1 degradation ( Figure 2A ). In contrast, we observed significant SM-induced BECN1 expression, LC3B-II conversion, SQSTM1 degradation, and a decrease in the SQSTM1:BECN1 ratio in HIV-T CM at 1 nM birinapant, 10 mM embelin, and 10 nM GDC-0152, suggesting induced autophagy (Figure 2A ). To establish further the induction of autophagy in SM-treated HIV-T CM , and not simply the activation of MAP1LC3B and SQSTM1 transcription, we used bafilomycin A 1 . Blots of cell lysates confirmed autophagic flux in HIV-T CM , with increased LC3B-II and SQSTM1 accumulation in bafilomycin A 1 -treated cells relative to vehicle controls ( Figure S2A ). Importantly, as SQSTM1 is also a substrate for CASP6 and CASP8 (as well as calpain 1) (Norman et al., 2010) , we still observed significant SQSTM1 degradation in the presence of a pan-cas-pase inhibitor ( Figure S2B ), and inhibition of the degradative steps of autophagy with bafilomycin A 1 had no effect on SM-induced XIAP or BIRC2 degradation in HIV-T CM ( Figure 2B ).
SMAC Mimetics Selectively Kill
Resting, HIV-Infected CD4+ T Cells SM can stimulate cell death alone or in combination with proapoptotic TNF-family ligands (Fulda, 2015) . Since both FASLG Figure S3 . The frequency of ANXA5-positive or ANXA5/PI-positive labeling is illustrated as a plot. Similar results were obtained using a cell (legend continued on next page) and FAS are upregulated in HIV-T CM , and SM treatment degrades XIAP and BIRC2, we examined the ability of SM to induce cell death in HIV-T CM and T CM . All SM induced cell death in A3.01, ACH-2, T CM , and HIV-T CM in a dose-dependent manner over 24 hr ( Figures 3A, S3 , and S4A-S4C). Neither HIV-T CM nor T CM were sensitive to SM at the lowest concentrations tested. However, we started to observe significant cell death in HIV-T CM at 10 nM birinapant, 10 nM GDC-0152, and 1 mM embelin. This cytotoxic effect was amplified at 100 nM birinapant, 100 nM GDC-0152, and 10 mM embelin, at which point cell death was approaching 90% and was similar to 1 mM staurosporine treatment. Conversely, we observed no cytotoxic effect in T CM until we used 100 nM birinapant, 100 nM GDC-0152, and 10 mM embelin, and, at these doses, cell death was just 3.5%-4.6% above basal levels. Importantly, we measured no SM-mediated increase in HIV p24 antigen release ( Figure 3B ) or cell-associated HIV gag RNA ( Figure 3C ), indicating that the SM were killing HIV-T CM in the absence of increased virus production. SM also induced the dose-dependent proteolysis of poly(ADP-ribose) polymerase 1 (PARP1) into an 89 kDa fragment, a measure of apoptosis, in the HIV-T CM but not in the T CM ( Figure 3D ). Additionally, in T CM , CASP8 cleavage only became significant at the highest concentrations tested, whereas HIV-T CM displayed significant CASP8 cleavage after the lowest doses of GDC-0152 and embelin ( Figure 3D ).
To determine if the preferential killing of HIV-T CM by SM was a direct effect on infected cells or secondary to toxic factors secreted into cell cultures, we examined a co-culture system in which we mixed HIV-T CM with T CM followed by exposure to SM. In these heterogeneous cultures, we observed no increase in cell death in either cell type in the absence of SM (p > 0.14; Figure 3E) . When the cultures were mixed at a T CM :HIV-T CM ratio of 9:1, SM induced more than 90% of HIV-T CM to undergo cell death (p < 0.001) in the absence of appreciable T CM death (p > 0.25). When this ratio was reversed to 1:9, SM again induced significant (>90%) HIV-T CM death (p < 0.001) but no significant T CM death. Importantly, staurosporine induced similar levels of cell death in both the homogeneous and the heterogeneous populations. Despite observing cell death, there was no measurable change in integrated HIV DNA copy number per cell as the dying cells are still present and their integrated HIV DNA still quantifiable ( Figure S4D ), which is consistent with other studies (Yin et al., 2015) . We then assessed whether the kinetics of killing uninfected T CM are slower compared with HIV-T CM by incubating the cells with birinapant for 96 hr. We observed no increase in cell death over this time, suggesting that at no point does T CM undergo cell death in response to SM to the same extent as the HIV-T CM ( Figure S4E ).
In leukemic cells, SM-treatment-induced expression of TNF is an important driver of SM-induced cell death (Petersen et al., 2007) . Therefore, we blocked TNF signaling with a specific neutralizing antibody. Neutralization of TNF had no effect on SM-mediated cell death . This correlated with our failure to detect the expression of TNFR on these cells and suggests that SM-mediated killing of HIV-T CM is not dependent upon TNF expression.
Next, using cells collected from HIV-infected patients undergoing ART, we evaluated the ability of SM to eliminate resting CD4+ T cells latently infected with HIV, which would lead to a decrease in levels of inducible HIV. As hypothesized, 24 hr SM treatment of these cells led to a significant decrease in HIV p24 antigen expression in a viral outgrowth assay, relative to vehicle-treated controls in the absence of globally increased cell death ( Figure 3G ). Importantly, SM treatment did not result in a reversal of latency, as we were unable to detect viral reactivation as measured by HIV gag RT-qPCR after 24 hr SM treatment in these cells ( Figure 3H ).
SM Induce Apoptosis in HIV-Infected CD4+ T Cells
Annexin-V (ANXA5)/propidium iodide (PI) double-positive staining is not exclusive to classic apoptosis. Upon necroptosis/ programmed necrosis induction, cells can be stained double positive, as their plasma membrane is damaged allowing PI and ANXA5 to penetrate the cell and bind to the phosphatidylserine located on the inner leaflet of the membrane. Therefore, we examined the effect of SM on HIV-T CM in the presence of pharmacological inhibitors of apoptosis (pan-caspase inhibitor z-VAD-FMK), autophagy (PI3K inhibitor wortmannin), and/or necroptosis (RIPK1 inhibitor necrostatin-1). Rescue from SMinduced cell death varied among donors, but we detected similar induced cell death patterns for birinapant, embelin, and GDC-0152 ( Figure 4A) . None of the samples tested showed a purely apoptotic phenotype, but all required either wortmannin or simultaneous application of z-VAD-FMK and necrostatin-1 death ELISA and are shown as a comparison in Figure S4B . DNA was extracted from HIV-T CM for Alu-long terminal repeat (LTR)-based nested qPCR and is shown in Figure S4C (D) T CM and HIV-T CM were treated with SM for 24 hr. Top, representative western blots of PARP1 and CASP8 cleavage (cPARP1 and cCASP8) using antibody to PARP1, CASP8, and ACTB. Bottom, densitometric analysis of blots, n = 4. (E) T CM and HIV-T CM were fluorescently labeled, mixed at different ratios, treated with SM or staurosporine for 24 hr, harvested, and stained with ANXA5 and PI; the frequency of ANXA5-positive or ANXA5/PI-positive labeling in the different populations was recorded by flow cytometry and illustrated as a dot plot. DNA was extracted from cultures for Alu-LTR-based nested qPCR and is shown Figure S4D n = 4. (F) HIV-T CM were pretreated with vehicle control or TNF neutralizing antibody 2 hr before incubation with SM for 24 hr. Cell death was measured using a cell death ELISA. n = 4. (G) Resting CD4+ T cells were isolated from HIV-infected donors on suppressive ART, viral load <20 copies mL À1 and CD4+ count >400 mL À1 for at least 6 months. Cells were treated with SM for 24 hr. Left, using the viral outgrowth assay, the frequency of latently infected cells was measured at day 14 with an HIV p24 antigen ELISA. The dotted line indicates the detection limit of the assay. Right, viability of cells after the 24 hr SM treatment. n = 5. (H) Resting CD4+ T cells isolated from HIV-infected donors on suppressive ART (viral load <20 copies mL À1 and CD4+ count >400 mL À1 for at least 6 months) were treated with SM or PHA/IL2 for 24 hr. RT-qPCR performed for HIV gag in supernatants from cells. Representative samples shown. n = 4. Each symbol represents one donor. Error bars show mean ± 95% confidence interval. For (G), error bars show mean ± SD. *p < 0.05 determined by Student's t test.
to arrest SM-induced cell death ( Figure 4A ). Although complete rescue did not occur, inhibition of either RIPK1 or caspases alone actually increased cell viability post SM treatment, suggesting that cells switch to the alternative pathway when a single pathway is inhibited. Since both the pan-caspase inhibitor and the RIPK1 inhibitor increased cell viability after SM treatment, we next performed temporal staining. All SM induced ANXA5 positivity first (apoptosis) but little dual PI positivity (necroptosis) at early time points, with temporally coincident staining commencing $9 hr post SM treatment indicating a classic apoptotic phenotype ( Figure 4B ).
As FAS, FASLG (both membrane-bound and soluble), XIAP, and BIRC2 are upregulated in HIV-T CM , we next tested whether varying expression of key components of the apoptotic and necroptotic response might contribute to the differential response to SM in T CM and HIV-T CM . We observed no consistent correlation of CASP8, RIPK1, RIPK3, FADD, or mixed lineage kinase domain like pseudokinase (MLKL) protein expression with sensitivity to SM in either T CM or HIV-T CM ( Figure 4C ). Moreover, there was no difference in basal expression of SQSTM1, ATG5, or ATG7. Collectively, these data indicate that HIV-T CM cell death in response to SM correlates with (1) HIV-induced expression of LC3B-II, BECN1, FAS, FASLG, XIAP, and BIRC2; (2) degradation of BIRC2 and XIAP; and (3) an increase in autophagy.
In the next series of experiments, we assessed the effect of SM on these same key players of the apoptotic and necroptotic response. At the doses tested, there was cleavage of RIPK1 and RIPK3 and an increase in the expression of ATG7 in HIV-T CM but not in T CM (Figure 4C ). The cleavage of RIPK1 and RIPK3 is consistent with reports that RIPK1 and RIPK3 are targets of CASP8 cleavage, and thus, as CASP8 is activated, RIPK1 and RIPK3 are cleaved (Moquin and Chan, 2010). Conversely, MLKL, an important necroptosis mediator (Yoon et al., 2016) , was increased in T CM but not in HIV-T CM (Figure 4C ). These data indicate that the SM induce apoptosis, but, when CASP8 is inhibited, the necroptotic pathway is invoked.
SM-Induced Apoptosis Is Dependent upon the Autophagy Machinery
Since wortmannin, an inhibitor of early stages of autophagy, inhibited SM-induced apoptosis despite IAP degradation, we next tested how autophagy affects SM-mediated cell death in HIV-T CM . In these experiments, inhibition of the autophagy conjugation cascades with RNAi for ULK1 (unc-51-like autophagy activating kinase 1), ATG5, ATG7, or SQSTM1 (Figure S5A ) led to increased cell viability in the presence of SM (Fig-ure 5A) . In contrast, we observed no effect on SM-induced death by blocking autophagic flux using either simultaneous RNAi for ATG2A and ATG2B (ATG2A/B), which causes the accumulation of immature unclosed autophagosomal structures ( Figure 5A ), or the inhibition of autophagosome-lysosome fusion using either chloroquine or bafilomycin A 1 ( Figure 5B) . Importantly, we observed no effect on SM-induced death with the inhibition of LC3-associated phagocytosis using RUN and cysteine rich domain containing beclin 1 interacting protein (RUBCN) silencing. Collectively, these data suggest that neither fully formed autophagosomes or autophagy-mediated degradation of cargo is required to induce cell death in response to SM because, if this were the case, a similar effect on cell death would occur regardless of autophagy stage inhibited. (shATG5), ATG7 (shATG7), RUBCN (shRUBCN), SQSTM1 (shSQSTM1), ULK1 (shULK1), or scrambled shRNA (shNS) were incubated with 100 nM birinapant, 100 nM GDC-0152, 10 mM embelin, or vehicle. Cell death was measured after 24 hr using a cell death ELISA. n = 4. Relative silencing efficiencies are shown in Figure S5A. (B) HIV-T CM were pretreated with vehicle, bafilomycin A 1 (Baf A1), or chloroquine (CQ) before incubation with 100 nM birinapant, 100 nM GDC-0152, or 10 mM embelin for 24 hr. Cell death was measured using a cell death ELISA. n = 4. Autophagy inhibition efficiencies are demonstrated in Figures S2A and S5B. (C) T CM and HIV-T CM were treated with 100 nM birinapant, 100 nM GDC-0152, or 10 mM embelin for 24 hr. Cells were lysed and CASP8 was immunoprecipitated (IP). The presence of ATG7, ATG12-ATG5, FADD, MLKL, cRIPK1, RIPK3, cRIPK3, and SQSTM1 and CASP8 was assayed by western blot. Left, representative western blots. Right, densitometric analysis of blots. n = 4. Each symbol represents one donor. Error bars show mean ± 95% confidence interval. *p < 0.05 determined by Student's t test.
A complex including RIPK1, CASP8, and FADD (a ripoptosome) is generated following the loss of BIRC2 and subsequent RIPK1 ubiquitination and degradation (Feoktistova et al., 2011; Tenev et al., 2011) . Having observed that the induction, but not the completion, of autophagy is required for SM-mediated killing of HIV-T CM , we next examined whether the autophagy machinery might provide a scaffold for the formation of a ripoptosome-like death-inducing signaling complex (DISC) composed of RIPK1, RIPK3, FADD, and CASP8 using co-immunoprecipitation. While the ripoptosome-like complex proteins RIPK1, RIPK3, and FADD co-immunoprecipitated with CASP8 in T CM and HIV-T CM , MLKL only co-immunoprecipitated with CASP8 in T CM ( Figure 5C ). In both T CM and HIV-T CM , proteins involved in early to middle stages of autophagy, including ATG5, ATG7, and SQSTM1, co-immunoprecipitated with CASP8 ( Figure 5C ). However, proteins that are important for earlier signaling in the autophagy process (BECN1 and ULK1) and those involved in later steps when autophagosomes fuse with lysosomes (syntaxin 17 [STX17] and lysosomal-associated membrane protein 1 [LAMP1]) did not co-immunoprecipitate with CASP8.
We next assessed whether autophagy proteins are required for efficient SM-mediated ripoptosome-like complex formation and activation in HIV-T CM using RNAi. ATG5 silencing abrogated the SM-mediated CASP8, RIPK1, and RIPK3 cleavage ( Figures  6A and S6A) and induced a significant negative change in RIPK1 co-immunoprecipitation with CASP8, RIPK3, ATG7, FADD, and SQSTM1 ( Figures 6B and S6B) . Similarly, ATG7 silencing abrogated the SM-mediated CASP8, RIPK1, and RIPK3 cleavage ( Figures 6A and S6A) , and pull-down of RIPK1 displayed a significant negative change in RIPK1 association with CASP8, RIPK3, ATG7, FADD, and SQSTM1 ( Figures 6B  and S6B ). Notably, MLKL did not associate with RIPK1 after either RNAi. As RIPK1 directly interacts with SQSTM1 (Sanz et al., 1999), we also silenced SQSTM1 and found a significant reduction in CASP8, RIPK1, and RIPK3 cleavage ( Figures 6C  and S7A ). Moreover, RNAi for SQSTM1 significantly reduced the SM-mediated association of RIPK1 with CASP8, RIPK3, ATG7, FADD, and ATG5 ( Figures 6D and S7B ). These findings correspond to the increase in cell viability observed upon SM treatment of SQSTM1 silenced cells ( Figure 5A ). These data indicate that RIPK1 requires SQSTM1 for the assembly and activation of the ripoptosome-like complex after SM treatment of HIV-T CM .
As RIPK1 directly interacts with SQSTM1, it is possible that ripoptosome-like complex components translocate to autophagosomal membranes. Therefore, we determined the stage of autophagosome formation at which ripoptosome-like complexes localize to autophagic structures by analyzing membranes in ATG2A/B silenced cells using differential centrifugation with LC3B-II and SQSTM1 used as markers of autophagosome membranes and autophagy substrates, respectively . In the control cells and in the absence of birinapant, LC3B (as LC3B-I), SQSTM1, FADD, and RIPK1 were located primarily in the cytosol, as indicated by their presence in the high-speed supernatant (HSS) fraction ( Figure 7A ). However, in the presence of birinapant and bafilomycin A 1 , LC3B accumulated, together with SQSTM1, in the low-speed pellet (LSP) and was resistant to proteinase K but sensitive to Triton X-100/proteinase K, indicating that the LC3B and SQSTM1 collected in this fraction were enclosed by autophagosomes. Conversely, SQSTM1, RIPK1, cleaved RIPK1, and FADD accumulated in the high-speed pellet (HSP), which was sensitive to both proteinase K and Triton X-100/proteinase K, indicating that these were not enclosed structures ( Figure 7A ). In ATG2A/ B silenced cells, proteinase K-sensitive LC3B-II and SQSTM1 accumulated in the HSP fraction in the absence of birinapant and bafilomycin A 1 . In the presence of birinapant and bafilomycin A 1 , they accumulated in both the LSP and HSP fractions, while proteinase K-sensitive RIPK1, cleaved RIPK1, and FADD were present only in the HSP fraction ( Figure 7A ). Collectively, this suggests that ATG2A and ATG2B are required for complete closure of autophagosomes, as LC3B-II-positive structures accumulate in their absence , and that RIPK1 and FADD do not translocate into closed autophagosomes after SM treatment.
DISCUSSION
To date, efforts to purge the latent HIV reservoir have often included a ''shock and kill'' strategy. This approach endeavors to reactivate viral production from latently infected reservoir cells (the shock), followed by clearance of these cells through a combination of viral and cell-mediated cytotoxicity (the kill) while ART prevents subsequent rounds of infection. Although latency reactivating agents have shown promise in cell lines, most are unable to induce substantive viral transcription in primary resting CD4+ T cells from patients on suppressive ART (reviewed in Spivak and Planelles, 2016), and reactivation from latency is often insufficient to induce cell death (Walker-Sperling et al., 2016) . Therefore, we used an alternative strategy designed to activate cell death pathways selectively in HIVinfected cells while sparing uninfected cells. We specifically targeted a cell death pathway because HIV has evolved mechanisms to evade apoptosis to promote cell survival. Importantly, the SM tested failed to reactivate viral production from latently infected reservoir CD4+ T cells collected from HIV-infected patients undergoing ART. These findings are in agreement with Pache et al. (2015) , who showed that the SM SBI-0637142 and LCL161 also failed to activate latent provirus in resting CD4+ T cells collected from HIV-infected patients undergoing ART.
Our data suggest that the selective killing of HIV-T CM by SM is dependent on the induction of autophagy and the translocation and interaction of FADD and the CASP8 homocomplex with ATG5 and SQSTM1. Autophagy proteins thus serve as a scaffold for the efficient assembly of a cytosolic DISC involving RIPK1 and RIPK3 that initiates apoptosis, connecting the induction of autophagy to apoptotic cell death ( Figure 7B) . Several independent pieces of evidence support this conclusion: (1) each of the SM studied induced autophagy, although analysis of SMinduced IAP degradation indicate that SM are capable of inducing apoptosis at concentrations that resulted in the complete autophagy independent-degradation of both XIAP and BIRC2; (2) RNAi for ATG5, ATG7, SQSTM1, or ULK1, and pharmacological inhibition of early autophagy events, abrogated the formation of the cytosolic DISC and inhibited subsequent CASP8 activation and cell death; and (3) neither simultaneous silencing of ATG2A and ATG2B nor the pharmacological inhibition of autophagosome-lysosome fusion protected cells from SM-mediated cell death. These data suggest that the SM-mediated autophagy does not influence cell death through the selective degradation of pro-or anti-apoptotic proteins, since, if the autophagic process were important, cell death would occur regardless of which stage of autophagy is inhibited.
Rather, our data indicate that the induction of autophagy affects cell survival. In this regard, self-oligomerized SQSTM1 can localize and recruit RIPK1 to the endoplasmic reticulumassociated autophagosome formation site independently of LC3 and is retained as autophagosomes mature (Goodall et al., 2016; Itakura and Mizushima, 2011) , while FADD is involved in tethering CASP8 and RIPK1 to autophagosomal membranes via ATG5 (Bell et al., 2008) . Here, we show that, following SM treatment of HIV-T CM , SQSTM1 coimmunoprecipitates with ATG5, CASP8, FADD, RIPK1, and RIPK3, that this is dependent upon the upstream proteins ATG5 and ATG7, and that both RIPK1 and FADD co-localize to the HSP with SQSTM1, defining a mechanism for how autophagy is involved in the control of cell survival or death.
The observed increase in autophagic markers in HIV-T CM is consistent with the hypothesis that HIV utilizes autophagosomal membranes as a scaffold for Gag processing and the production (A) HIV-T CM simultaneously transduced with a mixture of shRNA against ATG2A and ATG2B (shATG2A/B) or shNS were cultured in growth media supplemented with both 100 nM birinapant and 200 nM bafilomycin A 1 (Baf A 1 ) or vehicle for 2 hr. The post-nuclear supernatant (PNS) was separated into an LSP, an HSP, and a HSS fraction and subjected to western blotting. The sub-fractions were treated with proteinase K with or without Triton X-100. Representative western blots are shown. n = 4. Analysis of silencing is shown in Figure S5A. (B) Selected aspects of the key factors involved in the molecular regulation of autophagy and their roles in SM-mediated apoptosis of HIV-T CM . Ub, ubiquitin; Nec-1, necrostatin-1; Z-VAD, Z-VAD-fmk. of nascent virions, while controlling the antiviral proteolytic and degradative late stages of autophagy to avoid its own degradation (Borel et al., 2015; Campbell et al., 2015; Kyei et al., 2009) . These data are also consistent with the findings that autophagic flux is significantly impaired in CD4+ T cells from HIV-infected individuals, and peripheral blood mononuclear cells (PBMCs) from elite controllers contain significantly more autophagic vesicles and express more autophagic markers than normal progressors (Gomez-Mora et al., 2017) . Additionally, PBMCs from elite controllers were more responsive to sirolimus treatment, leading to an enhanced autophagic response and a greater reduction in virus production, illustrating the importance of autophagy in the cellular antiviral response (Nardacci et al., 2014) .
In summary, our findings identify a molecular mechanism whereby we can selectively induce apoptosis of HIV-T CM through the assembly of a ripoptosome-like DISC involving autophagy machinery without viral reactivation while sparing uninfected cells. These findings suggest that DIABLO/SMAC mimetics can play an important role in the development of a cure strategy for HIV.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Culture
The following cell lines were obtained through the NIH AIDS Reagent Program, Division of AIDS: ACH-2 (human; sex: female) and A3.01 (human; sex: female) from Dr. Thomas Folks (Buttke and Folks, 1992; Clouse et al., 1989; Folks et al., 1989) , HEK-293 (human; sex: female) from Dr. Andrew Rice (Graham et al., 1977) , and TZM-bl (human; sex: female) from Dr. John C. Kappes, Dr. Xiaoyun Wu and Tranzyme Inc. (Wei et al., 2002) . HEK-293 and TZM-bl cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (vol/vol) heat-inactivated FBS, 0.1 g L -1 streptomycin, 10 5 U L -1 penicillin (all Gibco) in 5% CO 2 at 37 C. ACH-2 and A3.01 cells were maintained in RPMI 1640 supplemented with 10% (vol/vol) heat-inactivated FBS, 10 mM 2-(4-(2-hydroxyethyl)piperazin-1-yl)ethanesulfonic acid (HEPES), 0.1 g L -1 streptomycin, 10 5 U L -1 penicillin (all Gibco) in 5% CO 2 at 37 C. NCTC clone 929 cells (murine; sex: male) were obtained from ATCC and were cultured in RPMI 1640 supplemented with 10% (vol/vol) heat-inactivated FBS in 5% CO 2 at 37 C.
Primary Human Cells
Whole blood (360 mL) was drawn from HIV-seronegative healthy volunteers, ages between 18 and 65 years, at UC San Diego Health Sciences. In accordance with the Human Research Protections Program of the University of California, San Diego, all samples were de-identified and donors remained anonymous. Thus, the authors did not obtain personal identifying information and cannot report on their sex, gender identity, or age. Samples were assigned to experimental protocols through simple random sampling. PBMC were isolated by density gradient centrifugation over Ficoll-Paque Plus (GE Healthcare). PHA stimulated PBMC (PHA-PBMC) were prepared by incubating 2 3 10 6 PBMC mL -1 in expansion media (RPMI 1640 supplemented with 20% [vol/vol] heat-inactivated FBS, 2 mM L-glutamine, 0.1 g L -1 streptomycin, 10 5 U L -1 penicillin [all Gibco], and 10000 U L -1 IL2 [Roche]) supplemented with 1 mg mL -1 PHA-P for 48 hr in 5% CO 2 at 37 C. Resting CD4+ T cells were purified from unstimulated PBMC by negative selection using the Miltenyi Biotec human CD4+ T Cell Isolation Kit supplemented with a biotin-conjugated anti-HLA-DR antibody (clone AC122; Miltenyi Biotec). Whole blood (200 mL) was drawn from HIV-infected volunteers aged between 18 and 65 years at the UCSD Mother-Child-Adolescent HIV Program. Individuals were selected on the basis of sustained suppression of plasma viral load (< 20 copies mL -1 for > 6 months) during ART and CD4+ T cell counts of > 400 cells mL -1 . In accordance with the Human Research Protections Program of the University of California, San Diego, all samples were de-identified and donors remained anonymous, thus the authors did not obtain personal identifying information and cannot report on their sex, gender identity, or age. Sample size was determined using a 2-sample 2-sided equality test with power (1-b) = 0.8, a = 0.05 and preliminary data where the minimum difference in outcome was at least 70%.
Ethical Statement
Venous blood was drawn from human subjects using protocols that were reviewed and approved by the Human Research Protections Program of the University of California, San Diego in accordance with the requirements of the Code of Federal Regulations on the Protection of Human Subjects (45 CFR 46 and 21 CFR 50 and 56) and were fully compliant with the principles expressed in the Declaration of Helsinki. All volunteers gave written informed consent prior to their participation.
Virus
The infectious molecular clone of HIV strain NL4-3 (pNL4-3) was obtained through the NIH AIDS Reagent Program from Dr Malcolm Martin (Adachi et al., 1986) . For virus preparation, HEK293T cells were transfected with proviral DNA using the calcium phosphate method (He et al., 1995) . Virus was harvested at 48 and 72 hr post-transfection then filtered through a 0.22 mm polyethersulfone filter (Millipore). Virus-containing supernatants were harvested 2 days later, and cellular debris was removed by centrifugation (5 min, 300 3 g) followed by filtration through a 0.22 mm polyethersulfone filter (Millipore). Virus was then expanded using 2 3 10 6 PHA-PBMC mL -1 in expansion media for 4 weeks in 5% CO 2 at 37 C. Fresh expansion media was added twice per week, and fresh PHA-PBMC were added once per week. Viral stocks were concentrated as previously described (Campbell and Spector, 2008) . Viral concentrates were subjected to a 6 to 18% iodixanol velocity gradient in 1.2% increments using OptiPrep (60% [w/v] iodixanol; Sigma) diluted in DPBS as previously described (Dettenhofer and Yu, 1999) . Briefly, supernatants were laid over the gradient and centrifuged for 1.5 hr at 37,500 rpm (250,000 3 g at r max ) in an SW41 Ti rotor using an L8-70M ultracentrifuge (both Beckman Coulter). Fourteen gradient fractions were collected and analyzed for total protein and HIV p24 content by SDS-PAGE and western blot analysis. HIV infectivity was calculated as the 50% tissue culture infectious doses (TCID 50 ) using PHA-PBMC and the Alliance HIV p24 antigen ELISA (Perkin Elmer) as described previously (Japour et al., 1993) and multiplicity of infection confirmed using TZMbl cells.
METHOD DETAILS
Establishment of Resting, HIV Infected CD4+ T Cells
This primary cell model is adapted from two previously established methods Saleh et al., 2011) and recapitulates the events of in vivo infection: namely infection, clonal expansion, and subsequent contraction. The first step relies upon the findings that in vitro latent infection can be established in resting CD4+ T cells through C-C motif chemokine ligand (CCL) 19 pretreatment
